Sevoflurane, a sigh of relief in COVID-19?
- PMID: 32416995
- PMCID: PMC7252148
- DOI: 10.1016/j.bja.2020.04.076
Sevoflurane, a sigh of relief in COVID-19?
Keywords: ARDS; COVID-19; ICU; sedation; sepsis; sevoflurane; volatile anaesthetic.
References
-
- WHO Coronavirus disease 2019 (COVID-19) situation report-93. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2... Available from:
-
- Ferrando C., Aguilar G., Piqueras L., Soro M., Moreno J., Belda F.J. Sevoflurane, but not propofol, reduces the lung inflammatory response and improves oxygenation in an acute respiratory distress syndrome model: a randomised laboratory study. Eur J Anaesthesiol. 2013;30:455–463. - PubMed
-
- Laferriere-Langlois P., d'Aragon F., Manzanares W. Halogenated volatile anesthetics in the intensive care unit: current knowledge on an upcoming practice. Minerva Anestesiol. 2017;83:737–748. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
